MedWatch

EMA recommends Covid-19 vaccination for children as young as 5

The European Medicines Agency's (EMA) special committee, the CHMP, has recommended the Pfizer-Biontech vaccine for children between the ages of 5 and 11.

Photo: ANDREJ IVANOV/AFP / AFP

On Thursday, the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommends the approval of Covid-19 developed by Pfizer and Biontech for use in children aged 5 to 11 years.

The extended indication of the vaccine, which is known as Comirnaty, will still need to be officially approved by the European Commission before children as young as 5 can receive their first shots. This approval, however, is typically considered a mere formality.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs